The Future of Gene-Based Medicines (featuring Ian Karp)

You've probably heard about gene editing to create hybrid species or designer babies. But what about its purpose to aid the wellbeing of humanity? Today, we're joined by Ian Karp on behalf of Intellia Therapeutics, a biotechnology company employing CRISPR-based gene editing to develop curative therapeutics for cancer and autoimmune disease. Tune in to hear his thoughts on recent clinical trial updates, how to effectively communicate the purpose of these therapies with the public, and what it's like to be at the forefront of medical innovation when it comes to gene editing. Check out the work that Intellia is doing: Ian Karp is a Senior Vice President at Intellia Therapeutics. He has over 25 years of expertise in the biopharmaceutical industry for investor relations, corporate communications, business development, and product commercialization.

You can listen to The Future of Gene-Based Medicines (featuring Ian Karp) online on Radio and Podcast. Open the player on this page to stream the available audio.

The Future of Gene-Based Medicines (featuring Ian Karp) is an episode from LearnOn Podcast: The Science Show By Kids, For Kids! by Jaansi Patel.

This episode is 00:26:21 long.

This episode was published on Oct 16, 2024.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from LearnOn Podcast: The Science Show By Kids, For Kids! when more episodes are available from the podcast feed.